血脂康治疗2型糖尿病合并高脂血症的临床疗效观察  

Effect of Xuezhikang on the treatment of patients with type 2 diabetes mellitus and hypedipidemia

作　　者：李小娟[1] 杨翠华[1] 谢莉萍[1] 王艳芳[1] 

机构地区：[1]中山大学附属第三医院保健科,广东广州510630

出　　处：《中国医学工程》2008年第3期189-191,共3页China Medical Engineering

摘　　要：目的探讨血脂康对2型糖尿病合并高脂血症患者脂代谢和血糖的影响。方法60例2型糖尿病合并高脂血症的患者在原降糖措施的基础上加服血脂康0.6g,2次/d,检测治疗前、治疗后4周、8周、12周血清总胆固醇(Tc)、甘油三酯(TG)、低密度脂蛋白-胆固醇(LDL-C)、高密度脂蛋白-胆固醇(HDL-C)、空腹血糖(FPG)及餐后2h血糖(2HPG)含量。并检测治疗前、治疗后12周糖化血红蛋白(GHbA1c)浓度。结果治疗前和治疗后4周Tc、TG、LDL-C分别降低为21.4%、34.3%和27.8%(P均<0.05);HDL-C升高16.5%(P<0.05)。空腹血糖(8.71±1.48)vs(7.14±1.22)mmol/L,餐后2h血糖(12.03±1.76)vs(9.27±1.44)mmol/L;糖化血红蛋白(7.1%±0.3%)vs(5.8%±0.1%)(均P<0.05)均明显下降。治疗前后各项指标无反复,均未见明显副作用。结论血脂康可降低2型糖尿病合并高脂血症患者血脂水平,同时也具有一定的降低血糖作用。【Objective】To investigate the effect of Xuezhikang on plasma glucose and lipids in type 2 diabetes mellitus with hypedipidemia.【Methods】Type 2 diabetes mellitus patients with dyslipidemia(n=60) were enrolled into the study.The levels of blood glucose lipids and GHbA1c were detected before the treatment of Xuezhikang(0.6 g,BID) and in 4,8 and 12 weeks after the treatments.【Results】After the treatment of Xuezhikang,dyslipidemia including Tc,TG,LDL-C reduced 21.4%,34.3% and 27.8% respectively(all P <0.05).H...

关 键 词：血脂康 2型糖尿病 高脂血症 

分 类 号：R587.1[医药卫生—内分泌]